Article

Study supports safety of femtosecond LASIK

A retrospective study evaluated complications and associated outcomes in eyes that underwent LASIK with femtosecond laser flap creation at a university-based refractive surgery center. A direct or indirect complication due to flap creation occurred in 44 (0.92%) of 4,772 eyes; there was no loss of best spectacle corrected visual acuity in any of the 44 eyes.

Key Points

Miami-Results of a retrospective, noncomparative study designed to evaluate complications associated with use of the femtosecond laser (IntraLase, Advanced Medical Optics) for LASIK flap creation show such events occur with a low incidence and do not result in adverse long-term sequelae, said Sonia H. Yoo, MD.

The findings come from a review of 4,772 eyes that underwent a femtosecond laser (IntraLASIK) procedure between September 2003 and June 2006 at the refractive surgery center at the Bascom Palmer Eye Intitute, University of Miami School of Medicine.

Within the series, 44 eyes (0.92%) experienced a direct or indirect complication due to flap creation. The surgery was aborted in only one eye. The final refractive and visual outcomes were favorable in all eyes that experienced a complication, and none had a loss of best spectacle corrected visual acuity (BSCVA), said Dr. Yoo, associate professor of ophthalmology, Bascom Palmer Eye Institute.

"No eyes required surgical intervention for DLK, and at follow-up after 1 year, all were emmetropic without loss of BSCVA," Dr. Yoo said.

Track, manage complications

The most common flap-related complication was premature breakthrough of gas through the epithelium within the flap margins, which occurred in eight eyes (0.17%).

The other complications included creation of an incomplete flap in three eyes secondary to suction loss and an irregular flap in one eye, where previous corneal scarring interfered with the lamellar pass.

In addition, eight eyes developed gas bubbles in the anterior chamber with a significant opaque bubble layer that interfered with the laser pupil tracking/iris registration technology. Dr. Yoo noted that the eyes with incomplete flaps underwent immediate retreatment with a second pass performed at the same level and subsequently underwent immediate excimer laser ablation.

In the eyes in which gas bubbles in the anterior chamber interfered with laser pupil tracking/iris registration, the ablation was performed without that technology or after waiting a few hours for the bubbles to clear.

Because the bubbles were transient, they were not considered true complications of the procedure. All eyes with transient light sensitivity syndrome were treated with additional topical steroids without any severe consequences.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
© 2025 MJH Life Sciences

All rights reserved.